Vitamins reverse endothelial dysfunction through regulation of eNOS and NAD(P)H oxidase activities

Hypertension

Volumn 41, Issue 3 I, 2003, Pages 534-539

  Ülker, Sibel ^a   McKeown, Pascal P ^a   Bayraktutan, Ulvi ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Antioxidants; Endothelium; Enzymes; Hypertension, experimental; Nitric oxide; Vitamins

Indexed keywords

ALPHA TOCOPHEROL; APOCYNIN; ASCORBIC ACID; DIPHENYLIODONIUM SALT; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; OXYGEN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SCAVENGER; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME REGULATION; ENZYME RELEASE; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THORACIC AORTA; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

ANIMALS; ANTIOXIDANTS; AORTA, THORACIC; ASCORBIC ACID; CULTURE TECHNIQUES; ENDOTHELIUM, VASCULAR; HYPERTENSION; MALE; NADPH OXIDASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, INBRED SHR; RATS, INBRED WKY; SUPEROXIDES; VASODILATION; VITAMIN E; VITAMINS;

EID: 0037337890     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000057421.28533.37     Document Type: Article

References (39)

1. Bayraktutan U. Free radicals, diabetes and endothelial dysfunction. Diabet Obes Metabol. 2002;4:224-238.
2. Panza JA, Casino PR, Kilcoyne RN, Quyyumi AA. Role of endothelium-derived NO in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation. 1993;87:1468-1474.
3. Taddei S, Virdis A, Mattei P, Salvetti A. Vasodilation to ACh in primary and secondary forms of human hypertension. Hypertension. 1993;21:929-933.
4. Tesmafariam B, Halpern W. Endothelium-dependent and endothelium-independent vasodilators in resistance arteries from hypertensive rats. Hypertension. 1988;11:440-444.
5. Luscher TF, Vanhoutte PM. Endothelium-dependent contractions to acetylcholine in the aorta of SHR. Hypertension. 1986;8:344-348.
6. Rodrigo E, Maeso R, Garcia R, Lahera V. Endothelial dysfunction in SHR: consequences of chronic treatment with losartan and captopril. J Hypertension. 1997;15:613-618.
7. Liao JK, Shin WS, Lee WY, Clark SL. Ox-LDL decreases expression of eNOS. J Biol Chem. 1995;270:319-324.
8. Goto K, Fujii K, Onaka U, Abe I, Fujishama M. ACE inhibitor prevents age-related endothelial dysfunction. Hypertension. 2000;36:581-587.
9. Hishikawa K, Nakaki T, Marumo T. Up-regulation of NOS by estradiol in human aortic endothelial cells. FEBS Lett. 1995;360:291-293.
10. McQuillan LP, Leung GK, Marsden PA. Hypoxia inhibits expression of eNOS via transcriptional and posttranscriptional mechanisms. Am J Physiol. 1994;267:H1921-H1927.
11. Chou TC, Yen MH, Li CY, Ding YA. Alterations of NOS expression with aging and hypertension in rats. Hypertension. 1998;31:643-648.
12. Gil-Longo J, Fernandez GD, Alvarez M, Siera M, Orallo F. Study of in vivo and in vitro resting vasodilator NO tone in normotensive and genetically hypertensive rats. Eur J Pharmacol. 1996;310:175-183.
13. Radaelli A, Mircoli L, Mori I, Mancia G, Ferrari AU. NO-dependent vasodilation in young SHR. Cardiovasc Res. 1998;32:735-739.
14. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide production. J Clin Invest. 1993;91:2546-2551.
15. Kerr S, Brosnan MJ, McIntyre M, Reid JL, Dominiczak AF, Hamilton CA. Superoxide anion production is increased in a model of genetic hypertension: role of the endothelium. Hypertension. 1999;33:1353-1358.
16. Butler R, Morris AD, Belch JJF, Hill A, Struthers AD. Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension. 2000;35:746-751.
17. Singh RB, Niaz MA, Rastogi SS, Shukla PK, Thakur AS. Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease. J Hum Hypertens. 1999;13:203-208.
18. Chen X, Touyz RM, Park JB, Schiffrin EL. Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR. Hypertension. 2001;38:606-611.
19. Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation. 1998;97:2222-2229.
20. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet. 1996;347:781-786.
21. Xu A, Vita JA, Keaney JF. Ascorbic acid and glutathione modulate the biological activity of S-nitrosoglutathione. Hypertension. 2000;36:291-295.
22. Newaz MA, Nawall NN. Effect of α-tocopherol on lipid peroxidation and total antioxidant status in SHR. Am J Hypertens. 1998;11:1480-1485.
23. Vaziri ND, Zhenmin N, Oveisi F, Trnavsk-Hobb DL. Effect of antioxidant therapy on blood pressure and NO synthase expression in hypertensive rats. Hypertension. 2000;36:957-964.
24. 15N] nitrate in biological fluids. Anal Biochem. 1982;126:131-138.
25. Stocker R, Frei B. Endogenous antioxidant defenses in human blood plasma. In: Sies H, ed. Oxidative Stress, Oxidants and Antioxidants. London: Academic Press; 1991:135-159.
26. Williams SB, Cusco JA, Roddy MA, Johnstone MT, Creager MA. Impaired NO-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol. 1996;27:567-574.
27. Hornig B, Arakawa N, Kohler C, Drexler H. Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure. Circulation. 1998;97:363-368.
28. Kugiyama K, Motoyama T, Hirashima O, Ohgushi M, Soejima H, Misumu K, Kawano H, Miyao Y, Yoshimira M, Ogawa H, Matsumura T, Sugiyama S, Yasue H. Vitamin C attenuates abnormal vasomotor reactivity in spasm coronary arteries in patients with coronary spastic angina. J Am Coll Cardiol. 1998;32:103-109.
29. Kleinert S. HOPE for cardiovascular disease prevention with ACE inhibitor ramipril. Lancet. 1999;354:841.
30. Noguchi T, Ikeda K, Sasaki Y, Yamamoto J, Seki J, Yamagata K, Nara Y, Hara H, Kakuta H, Yamori Y. Effects of vitamin E and sesamin on hypertension and cerebral thrombogenesis in SHRSP. Hypertens Res. 2001;24:735-742.
31. Elhaimeur F, Courdet-Masuyer C, Nicod L, Guyon C, Richert L, Berthelot A. Dietary vitamin C supplementation decreases blood pressure in DOCA-salt hypertensive male Sprague-Dawley rats and this is associated with increased liver oxidative stress. Mol Cell Biochem. 2002;237:77-83.
32. Newaz MA, Nawal NN, Rohaizan CH, Muslim N, Gapor A. α-Tocopherol increased nitric oxide synthase activity in blood vessels of SHR. Am J Hypertens. 1999;12:839-844.
33. Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH, Alexander RW, Ganz P. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med. 1986;315:1046-1051.
34. Bayraktutan U, Blayney L, Shah AM. Molecular characterization and localization of the NAD(P)H oxidase components gp91-phox and p22-phox in endothelial cells. Arterioscler Thromb Vasc Biol. 2000;20:1903-1911.
35. Hong H-J, Hsiao G, Cheng T-H, Yen M-H. Supplementation with tetrahydrobiopterin suppresses the development of hypertension in SHR. Hypertension. 2001;38:1044-1048.
36. Chaudiere J, Ferrari-Iliou R. Intracellular antioxidants: from chemical to biochemical mechanisms. Food Chem Toxicol. 1999;37:949-962.
37. Reaven P. Dietary and pharmacologic regimens to reduce lipid peroxidation in non-insulin-dependent diabetes mellitus. Am J Clin Nut. 1995; 62:1483S-1489S.
38. Bowry VW, Stocker R. Tocopherol-mediated peroxidation: the prooxidant effect of vitamin E on the radical-initiated oxidation of human low-density lipoprotein. J Am Chem Soc. 1993;115:6029-6044.
39. Baker TA, Milstien S, Katusic ZS. Effect of vitamin C on the availability of tetrahydrobiopterin in human endothelial cells. J Cardiovasc Pharmacol. 2001;37:333-338.